This research aims to assess the effectiveness of a cascade chatbot for family-based genetic testing in hereditary cancer syndromes.
Developed and tested a cascade chatbot for engaging family members of probands.
Evaluated acceptance and engagement levels among probands and their relatives.
Assessed the scalability of the digital tool for genetic testing.
The chatbot was highly acceptable to initial participants (proband).
It significantly engaged relatives effectively.
Indicated potential for scalability in genetic testing and cancer prevention strategies.
Abstract
A cascade chatbot was highly acceptable to probands and effectively engaged relatives. Scalable digital health tools may enhance cascade testing and support precision cancer prevention.